Clinical Trial Update: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial update evaluating leflunomide for high-risk smoldering multiple myeloma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• ARAVA (leflunomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Smoldering Plasma Cell Myeloma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING